Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. - sprookjes - yvandenbroek - TriplyDB

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q33680280

about

Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia An autism case history to review the systematic analysis of large-scale data to refine the diagnosis and treatment of neuropsychiatric disorders Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia Protectors or Traitors: The Roles of PON2 and PON3 in Atherosclerosis and Cancer PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death MLL-rearranged acute lymphoblastic leukaemia stem cell interactions with bone marrow stroma promote survival and therapeutic resistance that can be overcome with CXCR4 antagonism Bioinspired multivalent DNA network for capture and release of cells.Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia Integrative Analysis of MicroRNA-Mediated Gene Signatures and Pathways Modulating White Blood Cell Count in Childhood Acute Lymphoblastic Leukemia.Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia.Connective tissue growth factor is expressed in bone marrow stromal cells and promotes interleukin-7-dependent B lymphopoiesis.Regulatory network of GATA3 in pediatric acute lymphoblastic leukemia Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia Single molecule analysis of c-myb alternative splicing reveals novel classifiers for precursor B-ALL.Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group.A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL Immunologic minimal residual disease detection in acute lymphoblastic leukemia: a comparative approach to molecular testing A six gene expression signature defines aggressive subtypes and predicts outcome in childhood and adult acute lymphoblastic leukemia Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer.Regulator of myeloid differentiation and function: The secret life of Ikaros.Identification of differentially expressed genes associated with prognosis of B acute lymphoblastic leukemia.Vandetanib mediates anti-leukemia activity by multiple mechanisms and interacts synergistically with DNA damaging agents.Gene Expression Profiling of Ewing Sarcoma Tumors Reveals the Prognostic Importance of Tumor-Stromal Interactions: A Report from the Children's Oncology Group Improving access to novel agents for childhood leukemia.Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study.Apoptosis pathway signature for prediction of treatment response and clinical outcome in childhood high risk B-Precursor acute lymphoblastic leukemia.Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.Minimal Residual Disease in AML: Why Has It Lagged Behind Pediatric ALL?Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.Aurora B Overexpression Causes Aneuploidy and p21Cip1 Repression during Tumor Development.Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia.Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia.NF-κB and AKT signaling prevent DNA damage in transformed pre-B cells by suppressing RAG1/2 expression and activity Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy.Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma Advances in the Biology of Acute Lymphoblastic Leukemia-From Genomics to the Clinic High expression of ID family and IGJ genes signature as predictor of low induction treatment response and worst survival in adult Hispanic patients with B-acute lymphoblastic leukemia.

P2860

Q24597256-EBFD5C40-D5DE-420A-91CC-BA73AAC67B6B Q27008961-C9CF666F-34DE-4A34-9A83-2BA1988A806F Q27853385-C773994F-D811-48AF-90EC-D5E4DBB15C76 Q28384857-09F7D2E7-F455-4A9C-9C21-0A9A168FC267 Q28387637-1193D7B2-58D5-4282-B946-C4DB64054883 Q28658170-5FB9DE37-DE97-45C7-B687-D6B341BABF58 Q30528846-7189293B-BF9D-4098-A304-A5F5DEEB892E Q30538418-96EA1C6B-95D7-410D-B440-5A50E1642F6C Q33580638-00B96D6E-408A-4353-884D-7C1299500B37 Q33711119-CE09E688-D3F9-4C4C-856B-F52867A76A75 Q33828549-852114B9-7983-4D8F-AD91-9171A8B88933 Q33829399-C371717D-1150-48B1-AA99-743C2B18404F Q33985127-9D624568-60C1-48C1-88C3-136F5EBFA181 Q33996833-D001B80F-F9A4-4403-92FD-EE1FE24E164D Q33998291-7D63D17B-AF6D-4020-B443-ADB78B105E3A Q34217173-C91AABD7-75DF-4DC3-92E7-2821005BAA7B Q34425875-6AAA4B41-3AF7-4622-98FF-572BE4337E20 Q34477517-624C3E82-13DB-4EC7-8C5D-13911C7D2DB4 Q34820332-250DE7D7-AA67-481C-AA1C-5A08406D9762 Q35103926-33A65EDB-BEBD-4580-9ECF-13CC25865F43 Q35162503-16F436D9-F613-45DA-98E6-3149EDAF9C62 Q35569079-8AD8F56C-F232-464A-9BC9-C208E67DB3D6 Q35688154-06D8C5B1-9E09-41C5-ACE8-568D3152E412 Q35688742-97693651-6704-4F90-AC3C-0CB121DAAF98 Q35802220-E4B1DE7C-4369-415B-9D01-8B269A3BCF57 Q35835290-6D153A54-A703-4607-B054-B2235B987993 Q35876592-5A926559-2621-4238-BC86-579EA6A9F31D Q35885293-25DB6FCE-3D4B-4301-8E57-827DFE0301ED Q35992927-2CCA1BBA-0359-4BDD-80B9-1FDD710A3A3E Q36058255-0D7EDFC1-BC98-4F9D-A798-FC7F6CE056E4 Q36070046-604F7D31-96A9-427D-AB6C-54650A0880D0 Q36141916-2FAC27A8-CCB2-42B7-BF13-330D06A56E82 Q36143247-AD733778-4B46-43C0-BAD3-09BE04FC006E Q36351111-BA3FE83A-4BFE-4C21-862B-472F568947E2 Q36542815-608141D6-31DF-4B24-B444-32E1AF701892 Q36561755-67E077CD-460F-4A23-91BD-6EF6E446EC41 Q36666787-8B047E5F-4C37-4EE1-8A07-830D229D21E3 Q36717196-82591CAD-CDAE-41B5-9D01-D36103CCFC55 Q36752634-0CD251EB-6E33-444B-9B22-FA58ECF82B76 Q36765731-094C986D-C352-4424-A038-BC75C9523097

P2860

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q33680280

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Gene expression classifiers fo ...... acute lymphoblastic leukemia.

@ast

Gene expression classifiers fo ...... acute lymphoblastic leukemia.

@en

type

label

Gene expression classifiers fo ...... acute lymphoblastic leukemia.

@ast

Gene expression classifiers fo ...... acute lymphoblastic leukemia.

@en

prefLabel

Gene expression classifiers fo ...... acute lymphoblastic leukemia.

@ast

Gene expression classifiers fo ...... acute lymphoblastic leukemia.

@en

P1433

Q33680280-7B19503C-020B-42D3-85F2-AA7BC617CA33

P1476

Q33680280-50B4DEF5-C902-44FF-B62D-1A00B5DD1716

P2093

Q33680280-13515BBA-8D1F-4423-9AA8-E9E29F639ECA

Q33680280-1BF7312D-DC4A-4C39-83DE-5C1292D15F70

Q33680280-1FE36D0A-3BBB-43B0-B958-C45393380C0D

Q33680280-3B93CACD-93AD-42C7-9535-7C798A4A25AF

Q33680280-476E1AA2-9417-49B7-B47F-A25684B40223

Q33680280-550B5B5A-3EA8-4845-94AA-606FB07CEE76

Q33680280-5E6404E5-2934-4061-9DA5-7B5562850E1E

Q33680280-6545BF03-4920-4C9C-9844-872FEA9534AC

Q33680280-67D69440-BBE5-466C-829A-A446E877CCD1

Q33680280-77FD0E47-B832-42A5-A810-365E3CEB52C4

P2860

Q33680280-02D5111A-EDFF-446D-85A6-01165041682D

Q33680280-067F5E97-0882-461F-846E-56F23FD33464

Q33680280-069912A8-F907-4D43-8D06-A1929E337482

Q33680280-0B071F12-BDF2-498B-B07C-0C96C1AEA8AF

Q33680280-1305CB5A-1CCE-4ED6-BE66-47B580A79863

Q33680280-1857CC3E-EA59-42AF-AF77-4E5679A5788B

Q33680280-24602299-1B8D-4DA1-8F17-BFFD5E1606C4

Q33680280-2DA82D0F-F4D3-43EA-B700-606E526289EA

Q33680280-449BDA6B-CA82-4964-8985-33A80AFCD1D0

Q33680280-5EA6B6FC-5591-4443-80AC-A14120862881

P304

Q33680280-FF4CF2B6-EE53-40D3-9526-98A18BE9E796

P31

Q33680280-CD6E8FD2-8343-4E5B-B655-8FED0FA45B40

P356

Q33680280-CEE5A1C6-FB76-47FA-944B-2D2BC18AD448

P407

Q33680280-7089B867-7B8A-4710-9B2B-CAD52CCF3652

P433

Q33680280-4CAE8A62-EA3A-481F-A775-4C2E6F79AD6E

P478

Q33680280-E7E4BB0E-1520-479C-B746-4DAEC2208B62

P50

Q33680280-674FDC88-FF66-47F0-A5C2-F749ADB00BB7

Q33680280-9D97DBA1-611B-4350-9D6C-99E32BBB99BE

Q33680280-A23F8118-5559-4731-8CAE-4D7C5AF451B4

Q33680280-C7C703D4-C82B-470F-9F7D-A94AC436FDAD

P577

Q33680280-5889E5A9-E032-4A16-A643-B61419483324

P5875

Q33680280-011D9274-14F4-428D-A77D-02A48E23243D

P698

Q33680280-8FE37DFD-35D0-4474-9C07-77E3BA91032F

P921

Q33680280-D8829E74-10DA-46EA-9E09-C84496DFE416

P932

Q33680280-62BD2C5C-EEEB-4230-9E26-4FA86389770A

P356

BLOOD-2009-05-218560

P1433

P1476

Gene expression classifiers fo ...... acute lymphoblastic leukemia.

@en

P2093

Bruce M Camitta

http://www.w3.org/2001/XMLSchema#string

Carla S Wilson

http://www.w3.org/2001/XMLSchema#string

Cheryl L Willman

http://www.w3.org/2001/XMLSchema#string

Edward J Bedrick

http://www.w3.org/2001/XMLSchema#string

Gregory H Reaman

http://www.w3.org/2001/XMLSchema#string

Huining Kang

http://www.w3.org/2001/XMLSchema#string

I-Ming Chen

http://www.w3.org/2001/XMLSchema#string

James R Downing

http://www.w3.org/2001/XMLSchema#string

Kerem Ar

http://www.w3.org/2001/XMLSchema#string

Malcolm A Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Significance analysis of microarrays applied to the ionizing radiation response

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile

TTYH2, a human homologue of the Drosophila melanogaster gene tweety, is located on 17q24 and upregulated in renal cell carcinoma

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.

TTYH2, a human homologue of the Drosophila melanogaster gene tweety, is up-regulated in colon carcinoma and involved in cell proliferation and cell aggregation.

A FoxO-Smad synexpression group in human keratinocytes

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).

Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemia.

P304

1394-1405

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2009-05-218560

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

Charles G. Mullighan

Richard C Harvey

Stephen P Hunger

P577

2009-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38058747

http://www.w3.org/2001/XMLSchema#string

P698

19880498

http://www.w3.org/2001/XMLSchema#string

P921

P932

2826761

http://www.w3.org/2001/XMLSchema#string